FIELD: medicine, biochemistry. SUBSTANCE: invention relates to agent used for treatment of pathological osseous metabolism. Agent comprises at least one substance taken among the group consisting of osteoclastogenesis-inhibiting factor (OCIF), its homologs and variants and polysaccharide or its derivatives. As polysaccharide or its derivatives heparin, dextran sulfate and related substances can be used. Invention provides the excellent therapeutic effect in such species of pathological osseous metabolism as osteoporosis, hypercalcemia or chronic articulation rheumatism and shows the stable activity. EFFECT: enhanced effectiveness of agent, valuable medicinal properties. 6 cl, 10 dwg
Title |
Year |
Author |
Number |
COMPLEX COMPRISING OSTEOCLASTOGENESIS-INHIBITORY FACTOR (OCIF) AND POLYSACCHARIDE |
2002 |
- Jamamoto Siniti
- Okada Dzuniti
- Kurikhara Atsusi
- Numazava Taku
- Kondo Dzuniti
- Tsuda Eisuke
- Motizuki Siniti
- Nisi Khirotaka
- Mijazaki Khideki
|
RU2232594C2 |
PROTEIN BINDING SPECIFICALLY WITH OSTEOCLASTOGENESIS-INHIBITING FACTOR (OCIF) (VARIANTS), DNA ENCODING ITS (VARIANTS), DNA AS PROBE (VARIANTS), METHOD FOR PREPARING PROTEIN (VARIANTS), METHOD FOR SCREENING SUBSTANCE (VARIANTS), ANTIBODY (VARIANTS), METHOD FOR PREPARING POLYCLONAL ANTIBODY, HYBRIDOMA (VARIANTS), METHOD FOR PREPARING MONOCLONAL ANTIBODY, METHOD FOR ASSAY OF OCIF-BINDING PROTEIN, PHARMACEUTICAL COMPOSITION (VARIANTS) AND MEDICINAL AGENT (VARIANTS) |
1998 |
- Jamaguti Kiodzi
- Jasuda Khisataka
- Nakagava Nobuaki
- Sima Nobujuki
- Kinosaki Masakhiko
- Tsuda Eisuke
- Goto Masaaki
- Jano Kazuki
- Tomojasu Akikhiro
- Kobajasi Fumie
- Vasida Naokhiro
- Takakhasi Ken
- Morinaga Tomonori
- Khigasio Kandzi
|
RU2238949C2 |
METHOD FOR DIAGNOSING THE CASES OF BONE METABOLISM DISORDER DISEASES |
1998 |
- Jano Kazuki
- Kobajasi Fumie
- Goto Masaaki
- Vasida Naokhiro
- Tsuda Ehjsuke
- Khigasio Kandzi
- Jamada Josidzi
|
RU2203497C2 |
METHODS FOR TREATMENT OF COAGULOPATHIES WITH APPLICATION OF SULPHATED POLYSACCHARIDES |
2005 |
|
RU2347574C2 |
PROTEIN ABLE TO INHIBIT OSTEOCLASTOGENESIS (OCIF) (VARIANTS), CDNA, METHOD FOR PREPARING PROTEIN, METHOD FOR TREATMENT OF OSTEOPOROSIS, METHOD FOR TREATMENT AND/OR IMPROVEMENT OF BONE MASS RECOVERY, METHOD FOR TREATMENT OF INJURE ASSOCIATED WITH OSSEOUS METABOLISM, TRANSFORMED STRAIN ESCHERICHIA COLI PBK/01F10 AND PHARMACEUTICAL COMPOSITION |
1996 |
- Goto Masaaki
- Tsuda Ehjsuke
- Motizuki Siniti
- Jano Kazuki
- Kobajasi Fumie
- Sima Nobujuki
- Jasuda Khisataka
- Nakagava Nobuaki
- Morinaga Tomonori
- Ueda Masatsugu
- Khigasio Kandzi
|
RU2238948C2 |
GLAUCOMA TREATMENT |
2018 |
|
RU2759998C2 |
NOVEL PROTEINS AND METHODS OF THEIR PREPARING |
1996 |
- Goto Masaaki
- Tsuda Ehjsuke
- Motizuki Siniti
- Jano Kazuki
- Kobajasi Fumie
- Sima Nobujuki
- Jasuda Khisataka
- Nakagava Nobuaki
- Morinaga Tomonori
- Ueda Masatsugu
- Khigasio Kandzi
|
RU2194714C2 |
Siglec-15 ANTIBODY |
2010 |
- Khiruma Josikharu
- Tsuda Ejsuke
- Takizava Takesi
- Nakajama Makiko
|
RU2539790C2 |
ANTIBODY DIRECTED ON SIGLEC-15 PROTEIN, BOUND WITH OSTEOCLASTS |
2008 |
- Khiruma Josikharu
- Tsuda Ejsuke
|
RU2475499C2 |
POLYMERIC MODIFYING AGENTS AND PHARMACEUTICAL COMPOSITIONS |
2004 |
- Kasuja Judzi
- Khonma Masasi
|
RU2323227C2 |